LBTD (Lotus Bio-Technology Development) Return-on-Tangible-Equity: 0.00% (As of Dec. 2017)


What is Lotus Bio-Technology Development Return-on-Tangible-Equity?

Lotus Bio-Technology Development LBTD -99.99% Return-on-Tangible-Equity is 0.00% as of Dec. 2017.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Lotus Bio-Technology Development's annualized net income for the quarter that ended in Dec. 2017 was $-0.00 Mil. Lotus Bio-Technology Development's average shareholder tangible equity for the quarter that ended in Dec. 2017 was $-0.06 Mil. Therefore, Lotus Bio-Technology Development's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2017 was N/A%.

The historical rank and industry rank for Lotus Bio-Technology Development's Return-on-Tangible-Equity or its related term are showing as below:

LBTD's Return-on-Tangible-Equity is not ranked *
in the Agriculture industry.
Industry Median: 7.89
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Lotus Bio-Technology Development  (OTCPK:LBTD) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Lotus Bio-Technology Development Return-on-Tangible-Equity Related Terms


Lotus Bio-Technology Development Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Lotus Bio-Technology Development's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Bio-Technology Development Return-on-Tangible-Equity Chart

Lotus Bio-Technology Development Annual Data
Trend Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17
Return-on-Tangible-Equity
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Lotus Bio-Technology Development Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 Negative Tangible Equity 0.00 0.00 0.00

LBTD vs SNES, CVAT: Return-on-Tangible-Equity Comparison

For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Bio-Technology Development Return-on-Tangible-Equity vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Lotus Bio-Technology Development's Return-on-Tangible-Equity falls into.



Lotus Bio-Technology Development Return-on-Tangible-Equity Calculation

Lotus Bio-Technology Development's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2017 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2017 )  (A: Mar. 2016 )(A: Mar. 2017 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2017 )  (A: Mar. 2016 )(A: Mar. 2017 )
=-0.02/( (-0.061+-0.081 )/ 2 )
=-0.02/-0.071
=N/A %

Lotus Bio-Technology Development's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2017 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2017 )  (Q: Sep. 2017 )(Q: Dec. 2017 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2017 )  (Q: Sep. 2017 )(Q: Dec. 2017 )
=-0.004/( (0+-0.061)/ 1 )
=-0.004/-0.061
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2017) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Lotus Bio-Technology Development (LBTD) has a Return-on-Tangible-Equity of 0.00% as of Dec. 2017. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's Return-on-Tangible-Equity too high?
Lotus Bio-Technology Development's current Return-on-Tangible-Equity is 0.00%.
How does Lotus Bio-Technology Development's Return-on-Tangible-Equity compare to SNES and CVAT?
Lotus Bio-Technology Development's Return-on-Tangible-Equity of 0.00% can be compared against companies in the Agriculture industry. The industry median Return-on-Tangible-Equity is 7.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for an Agriculture company?
The median Return-on-Tangible-Equity among Agriculture companies is 7.89, based on 248 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Lotus Bio-Technology Development and its competitors. For the Agriculture industry, the median Return-on-Tangible-Equity is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Bio-Technology Development's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current Return-on-Tangible-Equity is 0.00% as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lotus Bio-Technology Development Business Description

Address 108 2559 Parkview Lane, Port Coquitlam, BC, CAN, V3C6M1
Lotus Bio-Technology Development Corp is actively seeking out new opportunities in the Organic and Bio-technology space.